As of November 17, 2025, the financial markets are grappling with a significant recalibration of expectations regarding Federal Reserve interest rate cuts. What was once a strong anticipation of imminent rate reductions has now given way to a more cautious outlook, with the perceived probability of a December 2025 cut
Mumbai, India – November 17, 2025 – MCX Gold futures are currently navigating a critical juncture, exhibiting a notable retreat from key trendline resistance levels and settling into a defined sideways market structure. This technical shift, observed on November 17, 2025, suggests a period of consolidation for the precious metal, with immediate
As November 2025 unfolds, the global financial markets find themselves at a critical juncture, characterized by a palpable sense of unease over elevated valuations in specific sectors and a pronounced "Great Rotation" of capital. Investors are navigating a complex landscape where the promise of innovation clashes with macroeconomic headwinds, prompting
November 2025 has ushered in a period of intense intraday volatility for both gold and silver, transforming the precious metals market into a high-stakes arena for day traders and short-term investors. These rapid price fluctuations, driven by a complex interplay of macroeconomic shifts, geopolitical tensions, and technical market dynamics, have
The financial markets are grappling with a turbulent period as recent labor market reports, particularly those reflecting October 2025 data, paint a picture of a weakening economy. With official government statistics delayed due to a federal shutdown, investors have been left to piece together a fragmented narrative from alternative data
India's trade deficit has reached an unprecedented high, hitting a staggering $41.68 billion in October 2025. This alarming figure is primarily a consequence of an extraordinary surge in gold and silver imports, which nearly tripled year-on-year, driven by robust festival demand and pent-up consumer buying. The record imbalance immediately
U.S. equity futures are signaling a mixed but largely cautious start to the trading day on November 17, 2025, with technology stocks once again taking the lead, while broader indices like the Dow Jones Industrial Average (DJIA) show signs of modest hesitation. Investors are bracing for a high-stakes week,
Vancouver, BC – November 17, 2025 – Equity Metals Corporation (TSXV: EQTY) continues to underscore the significant potential of its Silver Queen project in British Columbia, announcing a sustained series of high-grade silver equivalent discoveries and resource expansions that promise to redefine the asset's future. The ongoing exploration, characterized by consistent drill
November 17, 2025 – Bitcoin (BTC-USD) has officially entered a bear market in November 2025, experiencing a precipitous decline that has sent shockwaves through the cryptocurrency ecosystem and amplified a pervasive risk-off sentiment across traditional financial markets. The digital asset's sharp correction, driven by a confluence of persistent macroeconomic pressures, a
Nvidia (NASDAQ: NVDA), the undisputed titan of artificial intelligence (AI) chip manufacturing, is poised to release its fiscal third-quarter 2026 earnings report on Wednesday, November 19, 2025, after market close. This highly anticipated announcement, covering the period ending October 2025, arrives amidst a feverish AI boom that has propelled Nvidia's
As of November 17, 2025, U.S. financial markets are navigating a period of palpable anticipation and caution, with the Dow Jones Industrial Average (DJIA), Nasdaq Composite (NASDAQ), and S&P 500 (SPX) exhibiting largely subdued and mixed movements. Investors are keenly focused on two imminent and potentially market-defining events:
The S&P 500 has demonstrated remarkable resilience and growth in the period leading up to November 17, 2025, charting a significant upward trajectory driven by a confluence of powerful economic and technological forces. The benchmark index has not only recovered from earlier dips but has consistently reached new closing
Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive healthcare investments in November.
SenesTech, which reduces rodent birth rates without poison, had 43% revenue growth and huge catalysts. It has $10.2 million in cash, worth 68% of the SNES stock price - enough to cover its burn until cash flow positive.
